Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Projections for the CAGR of the Cancer Tumor Profiling Market Size From 2025 to 2034?

The market size for cancer tumor profiling has experienced swift growth lately. The market is expected to expand from $13 billion in 2024 to $14.97 billion in 2025, with a compound annual growth rate (CAGR) of 15.1%. The development during the historic period can be linked to a surge in cancer cases, progression in precision medicine initiatives and research partnerships, advancements in cancer diagnostics and early detection techniques, the presence of an extensive variety of targeted therapy choices, and favorable regulatory structures for cancer profiling examinations.

The market for cancer tumor profiling is set to experience a substantial expansion in the coming years. The market is predicted to reach$25.12 billion in 2029″, with a CAGR of 13.8%. This projected growth is largely due to the broader incorporation of immunotherapy and immunoprofiling in cancer treatments, advanced liquid biopsy and non-invasive methods for tumor profiling, the application of single-cell sequencing for enhanced tumor detailing, the enlargement of cancer screening and early detection programs, and an ascending demand for the profiling of rare and orphan cancer subtypes. Some prominent trends for the forecasted period include the incorporation of tumor profiling in regular clinical procedures, advancements in multi-omic strategies, the use of AI and machine learning in data interpretation, the development of personalized medication and targeted treatments, and progress in genomics and next-generation sequencing technologies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6053&type=smp

What are the Fundamental Drivers and Innovations Shaping the Cancer Tumor Profiling Market?

The escalating number of cancer occurrences worldwide are anticipated to bolster the expansion of the cancer and tumor profiling market. Cancer is characterized by the abnormal growth of some body cells which then invade other parts of the body. With the surge in cancer instances, the need for cancer tumor profiling escalates as it enables medical professionals to assess the disease’s intensity. For example, the US-based American Cancer Society reported an increase in diagnosed cancer cases from 1.9 million in 2023 to 2 million in 2024. Consequently, the rising global cancer occurrences fuel the expansion of the cancer and tumor profiling market.

How Is the Cancer Tumor Profiling Market Segmented?

The cancer tumor profilingmarket covered in this report is segmented –

1) By Cancer Type: Lung Cancer; Breast Cancer; Colorectal Cancer; Prostate Cancer; Melanoma; Ovarian Cancer; Stomach Cancer; Pancreatic Cancer; Thyroid Cancer; Other Cancer Types

2) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Immunohistochemistry (IHC); In Situ Hybridization (ISH); Microarray; Other Technologies

3) By Process Type: Genomics; Proteomics; Epigenetics; Metabolomics; Other Types

4) By Application: Personalized Medicine; Diagnostics; Biomarker Discovery; Prognostics; Research Applications

Subsegments:

1) By Lung Cancer: Non-Small Cell Lung Cancer (NSCLC); Small Cell Lung Cancer (SCLC)

2) By Breast Cancer: Hormone Receptor-Positive; Triple-Negative Breast Cancer; HER2-Positive Breast Cancer

3) By Colorectal Cancer: Colon Cancer; Rectal Cancer

4) By Prostate Cancer: Localized Prostate Cancer; Advanced Prostate Cancer

5) By Melanoma: Cutaneous Melanoma; Non-Cutaneous Melanoma

6) By Ovarian Cancer: Epithelial Ovarian Cancer; Non-Epithelial Ovarian Cancer

7) By Stomach Cancer: Gastric Adenocarcinoma; Gastrointestinal Stromal Tumors (GISTs)

8) By Pancreatic Cancer: Exocrine Pancreatic Cancer; Neuroendocrine Tumors

9) By Thyroid Cancer: Papillary Thyroid Cancer; Follicular Thyroid Cancer; Medullary Thyroid Cancer

10) By Other Cancer Types: Kidney Cancer; Bladder Cancer; Liver Cancer; Esophageal Cancer

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=6053&type=smp

Which Regions Are Driving the Next Phase of the Cancer Tumor Profiling Market Growth?

North America was the largest region in cancer and tumor profiling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer tumor profiling market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Key Trends Are Shaping the Future of the Cancer Tumor Profiling Market?

Heightened research and development activities are becoming a prominent trend in the cancer and tumor profiling market. The leading firms in this sector are concentrating their efforts on these activities as a means to fulfill consumer needs and consolidate their market position. Take, for example, QIAGEN N.V, a German corporation that creates sample and assay technology for various fields, including applied testing, pharmaceutical advancement, molecular diagnostics, and academic studies. They have recently announced the CE-marking and commercial introduction of therascreen PIK3CA RGQ PCR Kit in Europe. This tool is instrumental in identifying patients with PIK3CA mutations in breast cancer. Touted as the first diagnostic assay to allow testing of DNA from both plasma specimens and FFPE tissue, the therascreen PIK3CA test distinctively identifies an activating mutation in the phosphatidyl 3-kinase catalytic subunit alpha (PIK3CA) gene.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

How Is the Cancer Tumor Profiling Market Defined and What Are Its Core Parameters?

Cancer tumor profiling refers to a laboratory test that examines a sample of tumor tissue for specific genes, gene mutations (changes), proteins, or other biomarkers. Tumor profiling can help with treatment planning as well as predicting if cancer will recur or spread to other parts of the body.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6053

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model